These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18328166)

  • 1. Postinflammatory hyperpigmentation (PIH): the presenting sign of systemic lupus erythematosus.
    Taddio A; Franzil A; Lepore L
    Clin Exp Rheumatol; 2008; 26(1):156. PubMed ID: 18328166
    [No Abstract]   [Full Text] [Related]  

  • 2. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal.
    Park JY; Park JH; Kim SJ; Kwon JE; Kang HY; Lee ES; Kim YC
    J Cutan Pathol; 2017 Feb; 44(2):118-124. PubMed ID: 27766668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects.
    Siebenga PS; van Amerongen G; Klaassen ES; de Kam ML; Rissmann R; Groeneveld GJ
    Eur J Pain; 2019 May; 23(5):874-883. PubMed ID: 30597682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palisaded neutrophilic granulomatous dermatitis associated with systemic lupus erythematosus presenting with the burning rope sign.
    Gulati A; Paige D; Yaqoob M; Proby CM; Cerio R; Harwood CA
    J Am Acad Dermatol; 2009 Oct; 61(4):711-4. PubMed ID: 19577332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postinflammatory hyperpigmentation secondary to external insult: an overview of the quantitative analysis of pigmentation.
    Lamel SA; Rahvar M; Maibach HI
    Cutan Ocul Toxicol; 2013 Mar; 32(1):67-71. PubMed ID: 22667459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
    Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
    J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postinflammatory hyperpigmentation.
    Taylor S; Grimes P; Lim J; Im S; Lui H
    J Cutan Med Surg; 2009; 13(4):183-91. PubMed ID: 19706225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postinflammatory melanonychia due to chilblain.
    Hwang JI; Kim JE; Park HJ; Cho BK
    Int J Dermatol; 2012 Aug; 51(8):1010-1. PubMed ID: 22788826
    [No Abstract]   [Full Text] [Related]  

  • 9. Postinflammatory hyperpigmentation: A comprehensive overview: Epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique.
    Silpa-Archa N; Kohli I; Chaowattanapanit S; Lim HW; Hamzavi I
    J Am Acad Dermatol; 2017 Oct; 77(4):591-605. PubMed ID: 28917451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment.
    Kaufman BP; Aman T; Alexis AF
    Am J Clin Dermatol; 2018 Aug; 19(4):489-503. PubMed ID: 29222629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device.
    Tan KL; Kurniawati C; Gold MH
    J Drugs Dermatol; 2008 Aug; 7(8):774-7. PubMed ID: 18720695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Persistent Facial Postinflammatory Hyperpigmentation With Novel Pulse-in-Pulse Mode Intense Pulsed Light.
    Park JH; Kim JI; Kim WS
    Dermatol Surg; 2016 Feb; 42(2):218-24. PubMed ID: 26808182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
    Callender VD; St Surin-Lord S; Davis EC; Maclin M
    Am J Clin Dermatol; 2011 Apr; 12(2):87-99. PubMed ID: 21348540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral pigmentation is a specific feature of lupus erythematosus.
    Jamilloux Y; Cypierre A; Doffoel-Hantz V; Fauchais AL
    Lupus; 2015 Jan; 24(1):111-2. PubMed ID: 25135061
    [No Abstract]   [Full Text] [Related]  

  • 15. Postinflammatory hyperpigmentation: a common but troubling condition.
    Lacz NL; Vafaie J; Kihiczak NI; Schwartz RA
    Int J Dermatol; 2004 May; 43(5):362-5. PubMed ID: 15117368
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing postinflammatory hyperpigmentation in pediatric patients with skin of color.
    Heath CR
    Cutis; 2019 Feb; 103(2):71-73. PubMed ID: 30893390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after Q-switched ruby laser.
    Kato H; Araki J; Eto H; Doi K; Hirai R; Kuno S; Higashino T; Yoshimura K
    Dermatol Surg; 2011 May; 37(5):605-10. PubMed ID: 21457392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilaterally symmetrical alopecia with reticulated hyperpigmentation: a manifestation of cutaneous lupus erythematosus in a dog with systemic lupus erythematosus.
    Olivry T; Linder KE
    Vet Pathol; 2013 Jul; 50(4):682-5. PubMed ID: 23051917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment for postinflammatory hyperpigmentation: a systematic review.
    Tan MG; Kim WB; Jo CE; Nabieva K; Kirshen C; Ortiz AE
    J Dermatolog Treat; 2022 Aug; 33(5):2518-2526. PubMed ID: 34525885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatments for melasma and postinflammatory hyperpigmentation.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.